Alessia Fornoni University of MiamiUnited States

Dr. Fornoni is a tenured Professor of Medicine and Molecular and Cellular Pharmacology at the University of Miami Miller School of Medicine. She is the Chief of the Katz Family Division of Nephrology and Hypertension and serves as and Director and Chair of the Peggy and Harold Katz Drug Discovery Center. Dr. Fornoni gained experience in drug development at Hoffman-La Roche in Basel, and she is the funding scientist of several start-up companies. Her research is supported by grants from the NIH industry and private foundations. She has received prestigious awards: among them, she became a member of ASCI and AAP. Through her pioneering work on insulin signaling, cholesterol metabolism, and sphingolipid-related pathways, Dr. Fornoni uncovered novel pathogenetic mechanisms and therapeutic approaches for glomerular disorders. Her internationally recognized research findings, which are now being translated into humans with novel therapeutic applications, have challenged existing paradigms and have dramatically altered the research direction in these areas.

1 APRIL 2023

Time Session
15:45
16:45
Roberto Pecoits Filho Chairperson Arbor Research Collaborative for HealthUnited States
Sirirat Anutrakulchai Chairperson Faculty of Medicine, Khon Kaen UniversityThailand
  • A Consensus Meeting to Guide Optimal Pre-clinical Animal Studies in Translational Nephrology
    Alessia Fornoni Speaker University of MiamiUnited States
  • Insight Into CKDu Provided by the Global Kidney Health Atlas GKHA
    Aminu Bello Speaker aminu1@ualberta.caUniversity of AlbertaCanada
  • Toolkits to Facilitate the Implementation and Update of Guidelines
    Roberto Pecoits Filho Speaker Arbor Research Collaborative for HealthUnited States
  • Q and A
Plenary Halls 2 & 3
17:00
18:00
  • Acid-base and Electrolyte Abnormalities in Kidney Disease
    Andréa Stinghen Moderator Universidade Federal do ParanáBrazil
  • Acute Kidney Injury Clinical, Drugs, AKI-CKD Continuum 2
    Rolando Claure-Del Granado Moderator Hospital Obrero No 2 - C.N.S.Bolivia
  • Chronic Kidney Disease Complications (CVD, Hypertension, Anemia, BMD, Nutrition, Infection) 3
    Kraiwiporn KIATTISUNTHORN Moderator Siriraj HospitalThailand
  • Chronic Kidney Disease Diagnosis, Classification and Progression 2
    Richard Kitching Moderator Monash University, Monash Medical CenterAustralia
  • Chronic Kidney Disease, Experimental Models, Biomarkers, Precision Medicine 2
    Wenjun Ju Moderator wenjunj@med.umich.eduUniversity Of Michigan Medical CenterUnited States
  • Clinical Glomerulonephritis 3
    Hernan Trimarchi Moderator HOSPITAL BRITANICO DE BUENOS AIRESArgentina
  • Covid-19 and CKD
    Opeyemi Olabisi Moderator Duke UniversityUnited States
  • Curriculum
    Prapaipim Thirakhupt Moderator prapaipimt@yahoo.com
  • Diabetic Kidney Disease, Drugs and Treatments 2
    Dr Giorgina Barbara Piccoli Moderator gpiccoli@ch-lemans.frCHM Le MansFrance
  • Epidemiology, Outcomes and Health Service Research Related to CKD or Its Complications 2
    Sabine Karam Moderator Saint George Hospital University Medical CenterLebanon
  • Epidemiology, Outcomes and Health Services Research in Dialysis 2
    Ana Elizabeth Figueiredo Moderator anaef@pucrs.brBrazil
  • Essential Hypertension and Renovascular Kidney Disease
    Barry Freedman Moderator Wake Forest University School of Medicine United States
  • Genetics and Epigenetics (Including Common and Rare Genetic Diseases)
    Chairat Shayakul Moderator Faculty of Medicine Siriraj Hospital, THAILANDThailand
  • Haemodialysis, Haemodiafiltration and Vascular Access 2
    Brendan Smyth Moderator St George HospitalAustralia
  • Haemodialysis, Haemodiafiltration and Vascular Access 3
    Jonathan Himmelfarb Moderator jhimmelfarb@nephrology.washington.eduKidney Research Institute, University of Washington United States
  • Inflammation, Fibrosis, Matrix Biology and Oxidative Stress
    Youhua LIU Moderator University of PittsburghUnited States
  • Kidney Transplantation and Transplant Immunology 3
    Narayan Prasad Moderator Sanjay Gandhi Post Graduate Institute of Medical SIndia
  • Kidney Transplantation and Transplant Immunology 4
    Professor Yingyos Avihingsanon Moderator yingyos@hotmail.com
  • Late Breaking Clinical Trials
    Muh Geot Wong Moderator University of SydneyAustralia
  • Nephrotic Syndrome
    Alessia Fornoni Moderator University of MiamiUnited States
  • Other CKD 2
    Jie Dong Moderator jie.dong@bjmu.edu.cnPeking University First HospitalChina
  • Other KF (Kidney Failure)
    Tai Shuan Lai Moderator National Taiwan University HospitalTaiwan
  • Peritoneal Dialysis 2
    Piyatida Chuengsaman Moderator Thailand
  • Peritoneal Dialysis 3
    Afiatin Abdurahman Moderator
  • Training
    Naowanit Nata Moderator
  • Tropical Kidney Diseases (Viral Nephropathies, TB, Schistosomiasis, Malaria, Leptospirosis, Animal Venoms)
    Opas Traitanon Moderator
  • Urologic Disorders – Stones, Nephrocalcinosis
    Sritippayawan Suchai Moderator Siriraj Hospital Thailand
  • Vascular Biology and Endothelial Function
    Reiko Inagi Moderator Univ of Tokyo - Grad. School of MedicineJapan
Ballroom 2-3-4-Exhibition Hall

2 APRIL 2023

Time Session
08:30
10:00
Alessia Fornoni Chairperson University of MiamiUnited States
Muh Geot Wong Chairperson University of SydneyAustralia
  • CKD with Diabetes vs. Diabetic Nephropathy
    Hans-Joachim Anders Speaker hjanders@med.uni-muenchen.deLMU MUnichGermany
  • Treatment 1 (SGLT2, GLP1)
    Julia Weinmann Menke Speaker Medical Center of Johannes Gutenberg University MainzGermany
  • Treatment 2 (Finrenone, etc.)
    Vuddhidej Ophascharoensuk Speaker Chiang Mai UniversityThailand
  • Prevention of DKD
    Juliana Chan Speaker The Chinese University of Hong KongHong Kong, China
  • Q and A
Plenary Hall 1